Potential target networks for gene dysregulation found in patients with autism spectrum disorder

Potential target networks for gene dysregulation uniquely found in patients with autism spectrum disorder
Impaired social preference in Cntnap2 KO mice. a Schematic diagram used in the three-chamber social behavior tests. M: target conspecific; O: inanimate object. b Bar graph showing the percentage of the time spent toward a target conspecific or an inanimate object in control (n = 15) and Cntnap2 KO (n = 16) mice. Two-way ANOVA p = 0.0045; Sidak’s multiple comparison test, Control: mice vs object ****p < 0.0001, Cntnap2 KO: mice vs object p = 0.0634. c Bar graph showing preference index with significant differences between Cntnap2 KO and control mice. Two-tailed Welch’s t-test *p = 0.0441. Credit: Molecular Psychiatry (2022). DOI: 10.1038/s41380-022-01822-1

Professor Kim Min-sik's team of the Department of New Biology, DGIST, succeeded in identifying the cell-specific molecular network of autism spectrum disorder. It is expected to lay the foundation for treating autism spectrum disorder. The research is published in the journal Molecular Psychiatry.

Autism spectrum disorder is known to occur from and is a neuro-developmental disorder characterized by continuous impairment of social communication and interaction-related behaviors leading to limited ranges of behavioral patterns, interests, and activities, and repetitive behaviors.

Most patients have behavioral disorders, sometimes accompanied by other . Currently, since there is no accurate molecular diagnosis method, early diagnosis of autism spectrum disorder is made at a fairly late period, and there is no appropriate treatment.

Professor Kim Min-sik's team utilized the Cntnap2 defect model, a spectral disorder mouse model established by Professor Lee Yong-Seok's team at Seoul National University College of Medicine to extract prefrontal cortex tissue and performed mass spectrometry-based integrated quantitative proteomic and metabolomic analysis.

In addition, by comparing and analyzing this with previously reported big data of autism spectrum disorder patients, the team confirmed that problems occur in networks such as metabolism and synapses in excitable neurons.

Professor Kim Min-sik of the Department of New Biology said, "The multi-omics integrated analysis technology developed through this study has advanced the pathological understanding of autism spectrum disorder and made it possible to discover an integrated network ranging from molecular-level cell differentiation induced by a specific autism gene to biometric information."

He added, "We are trying to find the core network of spectrum disorder and discover treatment targets by conducting an integrated analysis of various models."

More information: Wooyoung Eric Jang et al, Cntnap2-dependent molecular networks in autism spectrum disorder revealed through an integrative multi-omics analysis, Molecular Psychiatry (2022). DOI: 10.1038/s41380-022-01822-1

Journal information: Molecular Psychiatry
Provided by Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Citation: Potential target networks for gene dysregulation found in patients with autism spectrum disorder (2022, December 14) retrieved 23 April 2024 from https://medicalxpress.com/news/2022-12-potential-networks-gene-dysregulation-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Screen time linked to autism spectrum disorder in boys

18 shares

Feedback to editors